Chapter IV: Solving The Riddle, A Consequential Approach
Contributing Author John Vandermosten, Senior Biotechnology Analyst The arc of HIV history has been developing over the last four decades. In the early days there was much we did not know, but as teams of physicians, researchers and patients increased their understanding of the disease, progress was made. Early efforts with repurposed cancer drugs gave way…
Read More5 Biotech Companies in Maryland That May Make History in 2021
Contributing Author: Gina Hagler These five biotechnology companies in Maryland may make history in 2021 because they have multiple therapeutic programs in trials for a variety of genetic diseases. #1 REGENXBIO is a publicly-traded company that develops products for one-and-done, single-dose solutions addressing genetic defects. Their products use adeno associated virus (AAV) viral vectors that…
Read MoreThe Berlin Patient’s Success Produces A Flurry of Activity
The Berlin Patient’s success provided optimism that there was a way to permanently disable HIV and eradicate it from an infected person. While a bone marrow transplant is not appropriate for most HIV patients, what we have learned from his experience has provided us clues to find a cure. Removing the door handle HIV uses…
Read More7 Cell Therapy Companies in Maryland Helping to Revolutionize Drug Discovery: The Latest News
Contributing Author: Gina Hagler Maryland has one of the largest life science clusters in the United States with more than 500 biotech companies. In addition to several state-of-the-art labs, Maryland is home to the NIH in Bethesda. Research opportunities, as well as BS and MS degree programs, are offered at Johns Hopkins in Baltimore and the…
Read MoreThe Race for a COVID Vaccine Foreshadows a Medical Revolution
Contributing Author Luke Williams, Sales and Marketing Conventional vaccine development can take many years, yet vaccines targeting the novel coronavirus were approved and began distribution in under 12 months. Pfizer, Moderna, and AstraZeneca have led the race, announcing promising interim results in their vaccine trials, with Pfizer’s and Moderna’s vaccines showing upwards of 90% effectiveness.…
Read MoreThe History of HIV Cure Research: Reaching for a Cure
Contributing Author: Gina Hagler A new immune deficiency illness came on the scene in 1981. In the years immediately following, four questions arose that indicated the uncertainty of the time: What was this illness? How was it transmitted? Could it be treated? Could it be cured? By 2004, when the number of people living with what…
Read MoreThe History of HIV Cure Research: The Latest Research in BioPharma
Contributing Author: Gina Hagler In the forty years since the HIV/AIDS pandemic began in 1981, researchers have learned a lot about this disease that destroys the immune system. Early on, they identified the method of transmission and the means of HIV replication. They went on to successfully turn what had been a deadly disease into a…
Read MoreARC of HIV History 2 – A Beginning and an End
Contributing Author John Vandermosten, Senior Biotechnology Analyst This is the second installment of our series on the Arc of HIV History which examines the earliest emergence of HIV and the progress that has been made until today. In Part 2 we look at the genesis of the first approved HIV drug and the first cure of…
Read MoreList of 88 Gene Therapies
Contributing Author Luke Williams, Sales and Marketing Biotechnology is a rapidly expanding sector where game-changing innovation is a daily occurrence. Gene and cell therapies are of particular interest because of the steep technology curve driving the technology platform. The gene and cell therapy industry is characterized by numerous small, competitive, agile businesses; each with a…
Read MoreIn Memory of Timothy Ray Brown
Contributing Author : Jeff Galvin, CEO and Founder American Gene Technologies A Message From the CEO of American Gene Technologies® Timothy Ray Brown – March 11, 1966 – September 29, 2020 Timothy Ray Brown was both a person and a turning point in the arc of HIV history. Timothy received a bone marrow transplant and…
Read More4 Global Trends That Will Affect HIV Cure Research in 2025
Contributing Author: Gina Hagler Researchers have been working on an HIV Cure since the first reports of the illness appeared in 1981. We now have effective treatment in the form of a cocktail of antiretroviral drugs that stop the HIV virus’s progression to full-blown AIDS, but It is not a cure. Despite their benefits, antiretrovirals…
Read MoreThe Arc of HIV History
Contributing Author John Vandermosten, Senior Biotechnology Analyst The Early Days When We Knew Nothing It is uncertain how the human immunodeficiency virus or HIV initially infected humans although there are educated guesses. Research has suggested that the virus crossed species from chimpanzees to humans in Africa early in the 20th century. Hunters would target chimpanzees or…
Read More